Eloxx Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$3.64M, a 49.1% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$19.3M, a 51.8% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$34.4M, a 47.9% increase from 2021.
  • Eloxx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$66M, a 97.3% decline from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$33.5M, a 33.8% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$19.3M -$3.64M +$3.51M +49.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$22.8M -$4.14M +$6.16M +59.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 -$28.9M -$5.48M +$5.47M +49.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$34.4M -$6.03M +$5.6M +48.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$40M -$7.14M +$3.1M +30.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$43.1M -$10.3M +$25.4M +71.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$68.6M -$11M -$2.54M -30.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$66M -$11.6M -$5.82M -100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$60.2M -$10.2M -$3.95M -62.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$56.2M -$35.7M -$28.1M -371% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$28.1M -$8.41M +$5.35M +38.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$33.5M -$5.81M +$5.68M +49.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$39.1M -$6.3M +$6.48M +50.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$45.6M -$7.59M +$6.73M +47% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$52.3M -$13.8M -$1.79M -14.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$50.6M -$11.5M +$2.63M +18.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-30
Q3 2019 -$53.2M -$12.8M -$1.42M -12.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$51.8M -$14.3M -$768K -5.67% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$51M -$12M -$3.43M -40.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$47.6M -$14.1M -$3.54M -33.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 -$44M -$11.4M -$7.36M -184% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$36.7M -$13.5M -$10.4M -326% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$26.3M -$8.55M -$5.92M -225% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$20.4M -$10.6M -$9.07M -602% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 -$11.3M -$4M -$1.79M -81% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$9.53M -$3.18M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$2.63M +$2.26M +46.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$1.51M +$2.25M +59.9% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-10
Q3 2016 -$2.21M -$1.06M -92% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
Q1 2016 -$4.89M -$3.66M -299% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 -$3.76M +$6.99M +65% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 -$1.15M +$4.03M +77.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q1 2015 -$20.8M -$1.22M +$904K +42.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$21.7M -$10.7M -$9.16M -576% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$12.6M -$5.19M -$3.43M -196% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$9.15M -$3.68M -$2.62M -247% Apr 1, 2014 Jun 30, 2014 10-K 2016-10-13
Q1 2014 -$6.53M -$2.13M -$1.08M -104% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$5.45M -$1.59M -$289K -22.2% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$5.16M -$1.75M -$507K -40.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$4.65M -$1.06M +$506K +32.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-10-09
Q1 2013 -$5.16M -$1.04M +$64.5K +5.81% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$5.22M -$1.3M +$156K +10.7% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$5.38M -$1.25M +$34K +2.66% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$5.41M -$1.57M +$1.27M +44.9% Apr 1, 2012 Jun 30, 2012 10-K 2014-09-29
Q1 2012 -$6.69M -$1.11M +$259K +18.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$6.94M -$1.46M +$48.9K +3.25% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 -$6.99M -$1.28M +$925K +42% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$7.92M -$2.84M Apr 1, 2011 Jun 30, 2011 10-K 2013-09-11
Q1 2011 -$1.37M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q4 2010 -$1.51M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$2.21M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.